On the role of placental growth factor in murine adipogenesis

Thrombosis Research

Volumn 120, Issue 3, 2007, Pages 399-405

  Christiaens, Valerie ^a   Voros, Gabor ^a   Scroyen, Ilse ^a   Lijnen, H Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adipogenesis; Adipose tissue; Angiogenesis; Obesity; Placental growth factor

Indexed keywords

MONOCLONAL ANTIBODY DC101; PLACENTAL GROWTH FACTOR;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; BODY WEIGHT; CELL DIFFERENTIATION; CONTROLLED STUDY; EX VIVO STUDY; FIBROBLAST; GENOTYPE; GONAD; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MALE; MOUSE; NEWBORN; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; SUBCUTANEOUS FAT; WILD TYPE;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DIETARY FATS; FIBROBLASTS; MALE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; PREGNANCY PROTEINS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 34249945830     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.10.007     Document Type: Article

References (32)

1. Rossner S. Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 26 (2002) S2-S4
2. Abelson P., and Kennedy D. The obesity epidemic. Editorial. Science 304 (2004) 1413
3. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
4. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
5. Crandall D.L., Hausman G.J., and Kral J.G. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4 (1997) 211-232
6. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R., et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 99 (2002) 10730-10735
7. Fukumura D., Ushiyama A., Duda D.G., Xu L., Tam J., Krishna V., et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 93 (2003) 88-97
8. Bråkenhielm E., Cao R., Gao B., Angelin B., Cannon B., Parini P., et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 94 (2004) 1579-1588
9. Hausman G.J., and Richardson R.L. Adipose tissue angiogenesis. J Anim Sci 82 (2004) 925-934
10. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 (1999) 9-22
11. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., and Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 88 (1991) 9267-9271
12. Voros G., Maquoi E., Demeulemeester D., Clerx N., Collen D., and Lijnen H.R. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 146 (2005) 4545-4554
13. Park J.E., Chen H.H., Winer J., Houck K.A., and Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269 (1994) 25646-25654
14. Autiero M., Luttun A., Tjwa M., and Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1 (2003) 1356-1370
15. Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9 (2003) 936-943
16. Lijnen H.R., Christaens V., Scroyen I., Voros G., Tjwa M., Carmeliet P., et al. Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 55 (2006) 2698-2704
17. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7 (2001) 575-583
18. Giles A.R. Guidelines for the use of animals in biomedical research. Thromb Haemost 58 (1987) 1078-1084
19. Vogel C.F., and Matsumura F. Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with induced adipocyte differentiation in mouse embryonic fibroblasts (MEFs) involves tyrosine kinase c-Src. Biochem Pharmacol 66 (2003) 1231-1244
20. Molinas C.R., Campo R., Dewerchin M., Eriksson U., Carmeliet P., and Koninckx P.R. Role of vascular endothelial growth factor and placental growth factor in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice. Fertil Steril 80 Suppl 2 (2003) 803-811
21. Hoying J.B., Boswell C.A., and Williams S.K. Angiogenic potential of microvessel fragments established in three-dimensional collagen gels. In Vitro Cell Dev Biol Anim 32 (1996) 409-419
22. Laitinen L. Griffonia Simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 19 (1987) 225-234
23. Maquoi E., Munaut C., Colige A., Collen D., and Lijnen H.R. Modulation of the expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51 (2002) 1093-1101
24. Tjwa M., Luttun A., Autiero M., and Carmeliet P. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res 314 (2003) 5-14
25. Luttun A., Tjwa M., and Carmeliet P. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann N Y Acad Sci 979 (2002) 80-93
26. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8 (2002) 831-840
27. Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 44 (2003) 3186-3193
28. Pipp F., Heil M., Issbrucker K., Ziegelhoeffer T., Martin S., van den Heuvel J., et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 92 (2003) 378-385
29. Hlatky L., Hahnfeldt P., and Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 94 (2002) 883-893
30. Cao R., Brakenhielm E., Wahlestedt C., Thyberg J., and Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 98 (2001) 6390-6395
31. Luttun A., Tjwa M., and Carmeliet P. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1: novel therapeutic targets for angiogenic disorders. Ann N Y Acad Sci 979 (2002) 80-93
32. Tjwa M., Luttun A., Autiero M., and Carmeliet P. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res 314 (2003) 5-14